The evaluation of their expression, along with HOXB3, could offer a valuable pattern for precise clinical assessment of IPMN subtype and grading (Supplementary Table S2). The gene discussed is HOXB3; the disease is pancreatic intraductal papillary-mucinous neoplasm.